Biotricity is trading 9.64% down at $0.05 on October 9, 2026, with no clear catalyst identified.
- Its news archive lists no announcement dated October 8; the broad market and healthcare sector are higher, offering no clear explanation for the decline.
- No reliable trading-volume figure or confirmed reason for the move was found. Recent weakness preceded another sharp decline, but evidence does not support linking it to a company event or broader market trend.